Search results
TIME100 Health: David Ricks
Time via Yahoo Finance· 3 hours agoThe U.S. Food and Drug Administration (FDA) approved Lilly’s tirzepatide, marketed as Mounjaro for diabetes, in 2022, and Zepbound for obesity& ...
Here's Why Eli Lilly Stock Remains a Screaming Buy
Motley Fool via Yahoo Finance· 5 hours agoIn the first quarter of 2024, the two products (which are the same drug, tirzepatide, sold under different labels) generated sales of over $2.3 billion....
So you've lost weight using Wegovy. Does that mean you can stop taking it?
San Francisco Chronicle· 20 hours agoMillions of Americans who have dropped pounds and boosted their health using popular obesity drugs...
Wegovy & other GLP-1 drugs to get coverage under Medicare Part D
AARP· 23 hours agoThe FDA recently approved a new use for Wegovy (semaglutide), the blockbuster anti-obesity drug, to reduce the risk of heart attacks ...
Taxpayers need to know how heavy a toll they'll be paying for weight-loss drug coverage
Chicago Sun-Times· 3 hours agoThe country’s obesity rates have been scaling up over the past two decades. Roughly 20% of boys and girls ages 2 to 19 were obese between 2017 and 2020, according to the U.S ...
TIME100 Health: Joel Habener, Dan Drucker, Svetlana Mojsov and Jens Juul Holst
Time via AOL· 3 hours agoDecades later, that understanding led to today’s revolution in diabetes and obesity treatments,...
How to Get Prescription Weight Loss Medication Without Insurance
MediaFeed via AOL· 20 hours agoWhether you’re on a weight loss journey of your own or not, you probably haven’t been able to avoid...
Why a legal fight against the manufacturers of Ozempic, Mounjaro, and other diabetes and weight-loss...
Philly.com· 6 hours agoThe patients live all over the country, but the lawsuits that play out in a Philadelphia courtroom...
Here's What Actually Happens When You Stop Taking Ozempic
Parade via Yahoo News· 2 days ago“It’s important to note that these medications have only been studied and approved for these chronic...
Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with...
WKBN 27 Youngstown· 3 hours agoFood and Drug Administration (FDA) has completed its 30-day review of the investigational new drug (IND) application for the use of bremelanotide, a melanocortin ...